Understanding of Compound Risk and Investment Decisions

Last registered on April 06, 2026

Pre-Trial

Trial Information

General Information

Title
Understanding of Compound Risk and Investment Decisions
RCT ID
AEARCTR-0018255
Initial registration date
March 31, 2026

Initial registration date is when the trial was registered.

It corresponds to when the registration was submitted to the Registry to be reviewed for publication.

First published
April 06, 2026, 7:55 AM EDT

First published corresponds to when the trial was first made public on the Registry after being reviewed.

Locations

There is information in this trial unavailable to the public. Use the button below to request access.

Request Information

Primary Investigator

Affiliation
Wageningen University & Research

Other Primary Investigator(s)

PI Affiliation
Utrecht University School of Economics
PI Affiliation
International Livestock Research Centre

Additional Trial Information

Status
On going
Start date
2025-11-24
End date
2027-04-01
Secondary IDs
Prior work
This trial does not extend or rely on any prior RCTs.
Abstract
This study aims to answer how individuals' understanding of compound risks, as opposed to preferences over compound risks, impacts investment behavior. We study this question using a lab-in-the-field experiment among a sample of 3143 pastoral household heads in Kenya and Ethiopia. We randomly vary the provision of a decision aid that helps individuals with processing compound risks and test the effects on investment decisions in an investment task.
External Link(s)

Registration Citation

Citation
Morsink, Karlijn, Kelvin Shikuku and Lotte van der Haar. 2026. "Understanding of Compound Risk and Investment Decisions." AEA RCT Registry. April 06. https://doi.org/10.1257/rct.18255-1.0
Experimental Details

Interventions

Intervention(s)
Intervention Start Date
2025-11-24
Intervention End Date
2025-12-30

Primary Outcomes

Primary Outcomes (end points)
- Investment behavior in investment task (see PAP)
- Reaction time
Primary Outcomes (explanation)

Secondary Outcomes

Secondary Outcomes (end points)
Secondary Outcomes (explanation)

Experimental Design

Experimental Design
The experimental design consists of a short lab-in-the-field experiment with two experimental arms, randomized at the household level:
1. Compound framing only (control)
2. Compound framing + Decision aid
In both arms, participants face an investment task involving compound risk. In the second arm, participants also receive a decision aid that supports the processing of compound risk. Because the way the compound risk is explained (the framing) may also influence understanding, we cross-randomize two alternative framings: an abstract framing and an intuitive framing. The abstract framing describes compound risks using tokens, whereas the intuitive framing uses livestock.
Experimental Design Details
Not available
Randomization Method
The first two randomizations were conducted in Stata 18 and stratified by districts and unit area of insurance. The third randomization was pre-programmed in the survey data-collection tool and revealed to the respondent and enumerator after the tasks were completed.
Randomization Unit
The project includes three household-level randomizations: (1) Randomization of version and cross-randomization of the framing of the lab-in-the-field task, (2) Randomization of order of the two investment tasks to measure compound risk ability and simple risk ability, (3) Randomization of selection for payment and of the task to be incentivized.
Was the treatment clustered?
No

Experiment Characteristics

Sample size: planned number of clusters
NA
Sample size: planned number of observations
3143 household heads
Sample size (or number of clusters) by treatment arms
1571 compound framing only, 1572 compound framing + decision aid
Minimum detectable effect size for main outcomes (accounting for sample design and clustering)
IRB

Institutional Review Boards (IRBs)

IRB Name
International Livestock Research Institute Institutional Research Ethics Committee
IRB Approval Date
2025-01-24
IRB Approval Number
ILRI-IREC2023-76/2
Analysis Plan

There is information in this trial unavailable to the public. Use the button below to request access.

Request Information